Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that it has won the prestigious ‘Bioprocessing Excellence in South Asia’ Award at the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023 held in Singapore earlier this month, via an exchange filing.
Biocon Biologics is a frontrunner in the global biosimilars industry and is committed to scientific innovation
Biocon Biologics Ltd has won the prestigious Bioprocessing Excellence in South Asia Award at the Asia-Pacific Bioprocessing Excellence Awards 2023 held in Singapore earlier this month.
Biocon Biologics was recognized as the winner as it garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey.
Lion TCR Pte Ltd, clinical-stage biotech company specialized in the development and commercialization of its proprietary engineered T Cell Receptor (TCR) products against infectious disease and its associated cancers, has been recognized as the ‘Most Promising Cell & Gene Therapy Startup in Asia’ category at the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022, organized by IMAPAC.